Data as of Sep 18, 2026 · Based on 3,315,446 AI responses across 10,525 prompts · See how Parse measures this
LabGenius Therapeuticslabgeniustx.com · Low evidenceLabGenius combines human and machine intelligence to discover and optimize therapeutic antibodies through its EVA platform, a highly automated discovery engine. The EVA platform rapidly identifies and co-optimizes complex antibodies—including multispecifics—across multiple properties to deliver selectivity-enhanced antibodies with best-in-class tumor-killing profiles for solid tumors. The approach is modality-agnostic and is advancing AI-designed antibody therapeutics through collaborations and partnerships, such as with LG Chem.
Parse Score